SynthesisPublic health nutrition2017
Cost-effectiveness of salt reduction to prevent hypertension and CVD: a systematic review.
Synthesis in Public health nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Systematic Review on International Salt Reduction Policy in Restaurants.International journal of environmental research and public health · 2020Pooled it
- Effectiveness and Feasibility of Taxing Salt and Foods High in Sodium: A Systematic Review of the Evidence.Advances in nutrition (Bethesda, Md.) · 2020Pooled it
- Monitoring and implementation of salt reduction initiatives in Africa: A systematic review.Journal of clinical hypertension (Greenwich, Conn.) · 2020Pooled it
- Theory-Based Mobile App Intervention to Promote Healthy Salt Intake Among Adults: Randomized Controlled Trial.JMIR human factors · 2025Trial
- Cost-Effectiveness of Salt Substitute and Salt Supply Restriction in Eldercare Facilities: The DECIDE-Salt Cluster Randomized Clinical Trial.JAMA network open · 2024Trial
- A self-monitoring urinary salt excretion level measurement device for educating young women about salt reduction: A parallel randomized trial involving two groups.Journal of clinical hypertension (Greenwich, Conn.) · 2019Trial
- Article
- Hypertensive Nephrosclerosis: Pathological Changes and Overlap with Diabetic Nephropathy.Cureus · 2025Review
- Health economics evidence for food system policy: a systematic review of reviews.Frontiers in nutrition · 2025Review
- Salt Reduction and Iodine Fortification Policies Are Compatible: Perspectives for Public Health Advocacy.Nutrients · 2024Review
- Cost-Effectiveness Analysis of Personalized Hypertension Prevention.Journal of personalized medicine · 2023Article
- Prioritization of intervention domains to prevent cardiovascular disease: a country-level case study using global burden of disease and local data.Population health metrics · 2023Article
- Economic effects of dietary salt reduction policies for cardiovascular disease prevention in Japan: a simulation study of hypothetical scenarios.Frontiers in nutrition · 2023Article
- Development of a short-form Chinese health literacy scale for low salt consumption (CHLSalt-22) and its validation among hypertensive patients.BMC nutrition · 2022Article
- Dietary Patterns of 479 Indonesian Adults and Their Associations with Sodium and Potassium Intakes Estimated by Two 24-h Urine Collections.Nutrients · 2022Article
- Protocol for the economic evaluation of the China Salt Substitute and Stroke Study (SSaSS).BMJ open · 2021Article
- Impact of the 2003 to 2018 Population Salt Intake Reduction Program in England: A Modeling Study.Hypertension (Dallas, Tex. : 1979) · 2021Article
- The cost-effectiveness of government actions to reduce sodium intake through salt substitutes in Vietnam.Archives of public health = Archives belges de sante publique · 2021Article
- Estimation of salt intake assessed by 24-h urinary sodium level among adults speaking different dialects from the Chaoshan region of southern China.Public health nutrition · 2021Article
- Preliminary Experiment on the Effect of 18% Substitute Salt on Home Blood Pressure Variability in Hypertensives.International journal of hypertension · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyse and compare the cost-effectiveness of different interventions to reduce salt consumption.
designA systematic review of published cost-effectiveness analyses (CEA) and cost-utility analyses (CUA) was undertaken in the databases EMBASE, MEDLINE (PubMed), Cochrane and others until July 2016. Study selection was limited to CEA and CUA conducted in member countries of the Organisation for Economic Co-operation and Development (OECD) in English, German or French, without time limit. Outcomes measures were life years gained (LYG), disability-adjusted life years (DALY) and quality-adjusted life years (QALY). Relevant aspects in modelling were analysed and compared. Quality assessments were conducted using the Drummond and Jefferson/British Medical Journal checklist.
settingOECD member countries. SUBJECTS: Mainly adults.
resultsFourteen CEA and CUA were included in the review which analysed different strategies: salt reduction or substitution in processed foods, taxes, labelling, awareness campaigns and targeted dietary advice. Fifty-nine out of sixty-two scenarios were cost-saving. The incremental cost-effectiveness ratio in international dollars (Intl.$; 2015) was particularly low for taxes, a salt reduction by food manufacturers and labelling (303 900 Intl.$/DALY). However, only six studies analysed cost-effectiveness from a societal perspective and quality assessments showed flaws in conducting and a lack of transparency in reporting.
conclusionsA population-wide salt reduction could be cost-effective in prevention of hypertension and CVD in OECD member countries. However, comparability between study results is limited due to differences in modelling, applied perspectives and considered data.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.